Interested In Using CBD Or Probiotics In Cosmetics? Ask Yourself Why – FDA’s Linda Katz

The answer to the ‘why’ question can help clarify whether a company is marketing a cosmetic or an unapproved drug, FDA’s cosmetics office director advised attendees at ICMAD’s 38th annual regulatory workshop in New York.

Slow-Down Sign_147945794_1200.jpg

The US Food and Drug Administration has yet to take a firm position on either CBD or probiotics in cosmetics, but advises companies to take a cautious approach to the ingredients’ use.

Presenting May 9 at the Independent Cosmetic Manufacturers and Distributors’ 38th annual regulatory workshop in New York, Linda Katz, director...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Ingredients & Safety

More from HBW Insight